Stabilization of HPV16 E6 protein by PDZ proteins, and potential implications for genome maintenance

Virology

Volumn 414, Issue 2, 2011, Pages 137-145

  Nicolaides, Lietta ^a   Davy, Clare ^a   Raj, Kenneth ^a,c   Kranjec, Christian ^b   Banks, Lawrence ^b   Doorbar, John ^a  

^a NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^b INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

E6; Genome maintenance; HPV; PDZ; Stability

Indexed keywords

MUTANT PROTEIN; PDZ PROTEIN; PROTEASOME; PROTEIN E6;

ARTICLE; CONTROLLED STUDY; EPISOME; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; KERATINOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEGRADATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN MOTIF; PROTEIN STABILITY; VIROGENESIS; VIRUS GENOME; WILD TYPE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; CELL ADHESION MOLECULES, NEURONAL; CELL LINE; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; MEMBRANE PROTEINS; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; PDZ DOMAINS; PROTEIN BINDING; PROTEIN STABILITY; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEINS;

HUMAN PAPILLOMAVIRUS; PAPILLOMAVIRIDAE;

EID: 79955907419     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2011.03.017     Document Type: Article

References (44)

1. Allen-Hoffmann B.L., Schlosser S.J., Ivarie C.A., Sattler C.A., Meisner L.F., O'Connor S.L. Normal growth and differentiation in a spontaneously immortalized near-diploid human keratinocyte cell line, NIKS. J. Invest. Dermatol. 2000, 114(3):444-455.
2. Charbonnier S., Nomine Y., Ramirez J., Luck K., Chapelle A., Stote R.H., Trave G., Kieffer B., Atkinson R.A. The structural and dynamic response of MAGI-1 PDZ1 with noncanonical domain boundaries to the binding of human papillomavirus E6. J. Mol. Biol. 2011, 406(5):745-763.
3. Doorbar J. Molecular biology of human papillomavirus infection and cervical cancer. Clin Sci Lond 2006, 110(5):525-541.
4. Forrester A., Farrell H., Wilkinson G., Kaye J., Davis-Poynter N., Minson T. Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted. J. Virol. 1992, 66(1):341-348.
5. Foster S.A., Demers G.W., Etscheid B.G., Galloway D.A. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest. J. Virol. 1994, 68(9):5698-5705.
6. Gardiol D., Kuhne C., Glaunsinger B., Lee S.S., Javier R., Banks L. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 1999, 18(40):5487-5496.
7. Glaunsinger B.A., Lee S.S., Thomas M., Banks L., Javier R. Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins. Oncogene 2000, 19(46):5270-5280.
8. Hoffmann R., Hirt B., Bechtold V., Beard P., Raj K. Different modes of human papillomavirus DNA replication during maintenance. J. Virol. 2006, 80(9):4431-4439.
9. Howley P.M., Lowy D.R. Papillomaviruses and Their Replication. Virology 2001, Vol. 2:2197-2229. Lippincott/The Williams and Wilkins Co, Philadelphia, Pa.
10. Huibregtse J.M., Scheffner M., Howley P.M. A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18. EMBO J. 1991, 10(13):4129-4135.
11. Kao W.H., Beaudenon S.L., Talis A.L., Huibregtse J.M., Howley P.M. Human papillomavirus type 16 E6 induces self-ubiquitination of the E6AP ubiquitin-protein ligase. J. Virol. 2000, 74(14):6408-6417.
12. Kehmeier E., Ruhl H., Voland B., Stoppler M.C., Androphy E., Stoppler H. Cellular steady-state levels of "high risk" but not "low risk" human papillomavirus (HPV) E6 proteins are increased by inhibition of proteasome-dependent degradation independent of their p53- and E6AP-binding capabilities. Virology 2002, 299(1):72-87.
13. Kiyono T., Hiraiwa A., Fujita M., Hayashi Y., Akiyama T., Ishibashi M. Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl Acad. Sci. U.S.A. 1997, 94(21):11612-11616.
14. Kranjec C., Banks L. A systematic analysis of HPV E6 PDZ substrates identifies MAGI-1 as a major target of HPV-16 and HPV-18 whose loss accompanies disruption of Tight Junctions 2010, J Virol.
15. Lambert P.F., Ozbun M.A., Collins A., Holmgren S., Lee D., Nakahara T. Using an immortalized cell line to study the HPV life cycle in organotypic "raft" cultures. Meth. Mol. Med. 2005, 119:141-155.
16. Latorre I.J., Roh M.H., Frese K.K., Weiss R.S., Margolis B., Javier R.T. Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J. Cell Sci. 2005, 118(Pt 18):4283-4293.
17. Laurson J., Khan S., Chung R., Cross K., Raj K. Epigenetic repression of E-cadherin by human papillomavirus 16 E7 protein. Carcinogenesis 2010, 31(5):918-926.
18. Lee C., Laimins L.A. Role of the PDZ domain-binding motif of the oncoprotein E6 in the pathogenesis of human papillomavirus type 31. J. Virol. 2004, 78(22):12366-12377.
19. Lee C., Wooldridge T.R., Laimins L.A. Analysis of the roles of E6 binding to E6TP1 and nuclear localization in the human papillomavirus type 31 life cycle. Virology 2007, 358(1):201-210.
20. Lepik D., Ilves I., Kristjuhan A., Maimets T., Ustav M. p53 Protein is a suppressor of papillomavirus DNA amplificational replication. J. Virol. 1998, 72(8):6822-6831.
21. Liu X., Yuan H., Fu B., Disbrow G.L., Apolinario T., Tomaic V., Kelley M.L., Baker C.C., Huibregtse J., Schlegel R. The E6AP ubiquitin ligase is required for transactivation of the hTERT promoter by the human papillomavirus E6 oncoprotein. J. Biol. Chem. 2005, 280(11):10807-10816.
22. Massimi P., Gammoh N., Thomas M., Banks L. HPV E6 specifically targets different cellular pools of its PDZ domain-containing tumour suppressor substrates for proteasome-mediated degradation. Oncogene 2004, 23(49):8033-8039.
23. Massimi P., Narayan N., Cuenda A., Banks L. Phosphorylation of the discs large tumour suppressor protein controls its membrane localisation and enhances its susceptibility to HPV E6-induced degradation. Oncogene 2006, 25(31):4276-4285.
24. McIntosh P.B., Martin S.R., Jackson D.J., Khan J., Isaacson E.R., Calder L., Raj K., Griffin H.M., Wang Q., Laskey P., Eccleston J.F., Doorbar J. Structural analysis reveals an amyloid form of the human papillomavirus type 16 E1-E4 protein and provides a molecular basis for its accumulation. J. Virol. 2008, 82(16):8196-8203.
25. Nagasaka K., Nakagawa S., Yano T., Takizawa S., Matsumoto Y., Tsuruga T., Nakagawa K., Minaguchi T., Oda K., Hiraike-Wada O., Ooishi H., Yasugi T., Taketani Y. Human homolog of Drosophila tumor suppressor Scribble negatively regulates cell-cycle progression from G1 to S phase by localizing at the basolateral membrane in epithelial cells. Cancer Sci. 2006, 97(11):1217-1225.
26. Nagasaka K., Pim D., Massimi P., Thomas M., Tomaic V., Subbaiah V.K., Kranjec C., Nakagawa S., Yano T., Taketani Y., Myers M., Banks L. The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction. Oncogene 2010, 29(38):5311-5321.
27. Nakagawa S., Huibregtse J.M. Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell. Biol. 2000, 20(21):8244-8253.
28. Narayan N., Subbaiah V.K., Banks L. The high-risk HPV E6 oncoprotein preferentially targets phosphorylated nuclear forms of hDlg. Virology 2009, 387(1):1-4.
29. Nguyen M.L., Nguyen M.M., Lee D., Griep A.E., Lambert P.F. The PDZ ligand domain of the human papillomavirus type 16 E6 protein is required for E6's induction of epithelial hyperplasia in vivo. J. Virol. 2003, 77(12):6957-6964.
30. Nomine Y., Masson M., Charbonnier S., Zanier K., Ristriani T., Deryckere F., Sibler A.P., Desplancq D., Atkinson R.A., Weiss E., Orfanoudakis G., Kieffer B., Trave G. Structural and functional analysis of E6 oncoprotein: insights in the molecular pathways of human papillomavirus-mediated pathogenesis. Mol. Cell 2006, 21(5):665-678.
31. Oh S.T., Longworth M.S., Laimins L.A. Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type 11. J. Virol. 2004, 78(5):2620-2626.
32. Park R.B., Androphy E.J. Genetic analysis of high-risk e6 in episomal maintenance of human papillomavirus genomes in primary human keratinocytes. J. Virol. 2002, 76(22):11359-11364.
33. Pim D., Banks L. Interaction of viral oncoproteins with cellular target molecules: infection with high-risk vs low-risk human papillomaviruses. APMIS 2010, 118(6-7):471-493.
34. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63(6):1129-1136.
35. Stewart D., Kazemi S., Li S., Massimi P., Banks L., Koromilas A.E., Matlashewski G. Ubiquitination and proteasome degradation of the E6 proteins of human papillomavirus types 11 and 18. J. Gen. Virol. 2004, 85(Pt 6):1419-1426.
36. Taylor E.R., Morgan I.M. A novel technique with enhanced detection and quantitation of HPV-16 E1- and E2-mediated DNA replication. Virology 2003, 315(1):103-109.
37. Thomas J.T., Hubert W.G., Ruesch M.N., Laimins L.A. Human papillomavirus type 31 oncoproteins E6 and E7 are required for the maintenance of episomes during the viral life cycle in normal human keratinocytes. Proc. Natl Acad. Sci. U.S.A. 1999, 96(15):8449-8454.
38. Thomas M., Glaunsinger B., Pim D., Javier R., Banks L. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene 2001, 20(39):5431-5439.
39. Thomas M., Massimi P., Navarro C., Borg J.P., Banks L. The hScrib/Dlg apico-basal control complex is differentially targeted by HPV-16 and HPV-18 E6 proteins. Oncogene 2005, 24(41):6222-6230.
40. Thomas M., Narayan N., Pim D., Tomaic V., Massimi P., Nagasaka K., Kranjec C., Gammoh N., Banks L. Human papillomaviruses, cervical cancer and cell polarity. Oncogene 2008, 27(55):7018-7030.
41. Tomaic V., Pim D., Banks L. The stability of the human papillomavirus E6 oncoprotein is E6AP dependent. Virology 2009, 393(1):7-10.
42. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189(1):12-19.
43. Wang H.K., Duffy A.A., Broker T.R., Chow L.T. Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev. 2009, 23(2):181-194.
44. Zhang Y., Dasgupta J., Ma R.Z., Banks L., Thomas M., Chen X.S. Structures of a human papillomavirus (HPV) E6 polypeptide bound to MAGUK proteins: mechanisms of targeting tumor suppressors by a high-risk HPV oncoprotein. J. Virol. 2007, 81(7):3618-3626.